Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 35969-75-6 | MDL No. : | MFCD07368185 |
Formula : | C6H4N2O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | NBHKYBWIGBFSRE-UHFFFAOYSA-N |
M.W : | 152.11 | Pubchem ID : | 15145501 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 38.45 |
TPSA : | 75.78 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.67 cm/s |
Log Po/w (iLOGP) : | 0.32 |
Log Po/w (XLOGP3) : | 0.79 |
Log Po/w (WLOGP) : | 0.8 |
Log Po/w (MLOGP) : | -1.32 |
Log Po/w (SILICOS-IT) : | -0.64 |
Consensus Log Po/w : | -0.01 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.55 |
Solubility : | 4.26 mg/ml ; 0.028 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.96 |
Solubility : | 1.66 mg/ml ; 0.0109 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.34 |
Solubility : | 6.98 mg/ml ; 0.0459 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 3.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.72 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
94% | With selenium(IV) oxide In 1,4-dioxane for 16 h; Reflux | To a stirred solution of 2-methyl-5-nitropyridine (3.0 g, 0.021 mol, 1 eq) in 1 ,4- dioxane (30 mL) at room temperature was added selenium dioxide (2.9 g, 0.026 mol, 1.2 eq) and stirred at reflux for 16 h. The reaction mixture was filtered, evaporated, diluted with ethyl acetate (50 mL) and washed with water (50 mL), dried over sodium sulphate and evaporated to get 5-nitropicolinaldehyde (3.12g, 94 percent). |
94% | With selenium(IV) oxide In 1,4-dioxane for 16 h; Reflux | Step 1 To a stirred solution of 2-methyl-5-nitropyridine (3.0 g, 0.021 mol, 1 eq) in 1,4-dioxane (30 mL) at room temperature was added selenium dioxide (2.9 g, 0.026 mol, 1.2 eq) and stirred at reflux for 16 h. The reaction mixture was filtered, evaporated, diluted with ethyl acetate (50 mL) and washed with water (50 mL), dried over sodium sulfate and evaporated to get 5-nitropicolinaldehyde (3.12 g, 94percent). |
35% | Stage #1: With selenium(IV) oxide; water In 1,4-dioxane for 4 h; Heating / reflux Stage #2: With sodium hydrogencarbonate In 1,4-dioxane; diethyl ether; water |
A mixture of 2-methyl-5-nitropyridine (3 g), selenium (IV) (2.9 g), 1,4- dioxane (25 mL) and water (0.5 mL) was refluxed for 4 hrs. The resulting black solid was filtered through Celite° bed and washed with ether. The filtrate was treated with saturate aqueous NaHC03 and filtered again. The filtrate was extracted with ether twice and the solvent was concentrated. The residue was purified with a short silica gel column eluted with 20percent ethyl acetate in hexane to give 1.0 g of orange precipitate 2 (35percent yield). 1H NMR (CD2Cl2): 8 10.15 (s, 1H), 9.55 (s, 1H), 8.7 (d, 1H), 8.15 (s, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60% | With diisobutylaluminium hydride In dichloromethane; toluene at -78 - 20℃; for 3 h; Inert atmosphere | To a suspension of methyl 5-nitropicolinate (LIX) (1.282 g, 7.03 mmol) in DCM (25 mL) stirred at -78°C under argon was slowly added DIBAL (1M in toluene) (9.14 mL, 9.14 mmol). The solution was allowed to warm to room temperature over 3 h. An aqueous solution of potassium sodium tartrate was added, diluted further with water and DCM. The solution was stirred at room temperature for another 30 min before the organic layer was separated. The aqueous layer was extracted 2x DCM, combined with the organic layer, dried over MgS04, filtered and evaporated under reduced pressure. The residue was purified by column chromatography to produce 5- nitropicolinaldehyde (LX) as a brown oil (0.64 g, 4.2 mmol, 60percent yield). 1H NMR (DMSO-d6) 6 ppm 8.17 (d, J=9Hz, 1H), 8.81 (dd, J=9Hz, J=2Hz, 1H), 9.56 (d, J=2Hz, 1H), 10.08 (s, 1H). |
60% | With diisobutylaluminium hydride In dichloromethane; toluene at -78 - 20℃; for 3 h; Inert atmosphere | Step 1 To a suspension of methyl 5-nitropicolinate (CX) (1.282 g, 7.03 mmol) in DCM (25 mL) stirred at -78° C. under argon was slowly added DIBAL (1M in toluene) (9.14 mL, 9.14 mmol). The solution was allowed to warm to room temperature over 3 h. An aqueous solution of potassium sodium tartrate was added, diluted further with water and DCM. The solution was stirred at room temperature for another 30 min before the organic layer was separated. The aqueous layer was extracted 2*DCM, combined with the organic layer, dried over MgSO4, filtered and evaporated under reduced pressure. The residue was purified by column chromatography to produce 5-nitropicolinaldehyde (CXI) as a brown oil (0.64 g, 4.2 mmol, 60percent yield). 1H NMR (DMSO-d6) δ ppm 8.17 (d, J=9 Hz, 1H), 8.81 (dd, J=9 Hz, J=2 Hz, 1H), 9.56 (d, J=2 Hz, 1H), 10.08 (s, 1H). |
60% | With diisobutylaluminium hydride In dichloromethane; toluene at -78 - 20℃; for 3 h; Inert atmosphere | To a suspension of methyl 5-nitropicolinate (LIX) (1.282 g, 7.03 mmol) in DCM (25 mL) stirred at -78°C under argon was slowly added DIBAL (1M in toluene) (9.14 mL, 9.14 mmol). The solution was allowed to warm to room temperature over 3 h. An aqueous solution of potassium sodium tartrate was added, diluted further with water and DCM. The solution was stirred at room temperature for another 30 min before the organic layer was separated. The aqueous layer was extracted 2x DCM, combined with the organic layer, dried over MgS04, filtered and evaporated under reduced pressure. The residue was purified by column chromatography to produce 5-nitropicolinaldehyde (LX) as a brown oil (0.64 g, 4.2 mmol, 60percent yield). NMR (DMSO-d6) δ ppm 8.17 (d, J=9Hz, 1H), 8.81 (dd, J=9Hz, J=2Hz, 1H), 9.56 (d, J=2Hz, 1H), 10.08 (s, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60% | at 0℃; for 2 h; | To a stirred solution of 5-nitropicolinaldehyde (350 g, 2.3mmol, 1.0 eq) in methanol (10 mL) was added NaBH4 (82 mg, 2.3 mmol, 1.0 eq) at 0 °C and resulting reaction mixture was stirred for 2 h. The reaction mixture was evaporated and residue dissolved in ethyl acetate (20 mL), washed with brine (30 mL), dried over sodium sulphate, evaporated to get (5-nitropyridin-2-yl)methanol (0.210 g, 60 percent). |
60% | With sodium tetrahydroborate In methanol at 0℃; for 2 h; | Step 2 To a stirred solution of 5-nitropicolinaldehyde (350 g, 2.3 mmol, 1.0 eq) in methanol (10 mL) was added NaBH4 (82 mg, 2.3 mmol, 1.0 eq) at 0° C. and resulting reaction mixture was stirred for 2 h. The reaction mixture was evaporated and residue dissolved in ethyl acetate (20 mL), washed with brine (30 mL), dried over sodium sulfate, evaporated to get (5-nitropyridin-2-yl)methanol (0.210 g, 60percent). |
[ 1122-72-1 ]
6-Methyl-2-pyridinecarboxaldehyde
Similarity: 0.64
[ 30651-24-2 ]
5-Nitro-2-pyridinecarboxylic acid
Similarity: 0.87
[ 51984-61-3 ]
2-Methyl-5-nitropyridin-3-amine
Similarity: 0.84
[ 30651-24-2 ]
5-Nitro-2-pyridinecarboxylic acid
Similarity: 0.87
[ 51984-61-3 ]
2-Methyl-5-nitropyridin-3-amine
Similarity: 0.84